Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Dane C. Andreeff net worth and biography

Dane Andreeff Biography and Net Worth

CEO of Helius Medical Technologies

Mr. Andreeff is the General Partner and Portfolio Manager of Maple Leaf Partners, L.P. and the President of Andreeff Equity Advisors, L.L.C. Mr. Andreeff has managed investment portfolios since 1996 for Andreeff Equity, L.P., Andreeff Overseas Ltd. and Clover Partners, LP. Prior to managing portfolios, Mr. Andreeff worked as an associate analyst at Furman Selz and Granite Capital International Group. Currently, Mr. Andreeff serves as a Director of TraceSecurity Inc., HDL Therapeutics, Inc. and Myocardial Solutions, Ltd.

Mr. Andreeff received his Master's degree in Economics from the University of Texas at Arlington in 1991 and Bachelor's degree in Economics from the University of Texas at Arlington in 1989.

What is Dane C. Andreeff's net worth?: The estimated net worth of Dane C. Andreeff is at least $15,025.92 as of December 14th, 2023. Mr. Andreeff owns 16,512 shares of Helius Medical Technologies stock worth more than $15,026 as of December 22nd. This net worth estimate does not reflect any other assets that Mr. Andreeff may own. Additionally, Mr. Andreeff receives an annual salary of $469,170.00 as CEO at Helius Medical Technologies. Learn More about Dane C. Andreeff's net worth.
How old is Dane C. Andreeff?: Mr. Andreeff is currently 58 years old. There are 1 older executives and no younger executives at Helius Medical Technologies. Learn More on Dane C. Andreeff's age.
What is Dane C. Andreeff's salary?: As the CEO of Helius Medical Technologies, Inc., Mr. Andreeff earns $469,170.00 per year. Learn More on Dane C. Andreeff's salary.
How do I contact Dane C. Andreeff?: The corporate mailing address for Mr. Andreeff and other Helius Medical Technologies executives is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. Helius Medical Technologies can also be reached via phone at (877) 564-0008 and via email at [email protected]. Learn More on Dane C. Andreeff's contact information.
Has Dane C. Andreeff been buying or selling shares of Helius Medical Technologies?: Dane C. Andreeff has not been actively trading shares of Helius Medical Technologies during the last quarter. Most recently, on Thursday, December 14th, Dane Andreeff bought 5,000 shares of Helius Medical Technologies stock. The stock was acquired at an average cost of $8.10 per share, with a total value of $40,500.00. Following the completion of the transaction, the chief executive officer now directly owns 16,512 shares of the company's stock, valued at $133,747.20. Learn More on Dane C. Andreeff's trading history.
Who are Helius Medical Technologies' active insiders?: Helius Medical Technologies' insider roster includes Dane Andreeff (CEO), and Jeffrey Mathiesen (CFO). Learn More on Helius Medical Technologies' active insiders.

Dane C. Andreeff Insider Trading History at Helius Medical Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2023	Buy	5,000	$8.10	$40,500.00	16,512
11/30/2023	Buy	2,000	$6.37	$12,740.00	12,551
8/30/2023	Buy	5,000	$7.64	$38,200.00	11,420
8/28/2023	Buy	5,078	$6.37	$32,346.86	8,774
12/16/2022	Buy	1,600	$12.50	$20,000.00	6,650
11/22/2022	Buy	200	$14.00	$2,800.00	4,371
9/12/2022	Buy	177	$27.00	$4,779.00	2,896
8/24/2022	Buy	504	$32.50	$16,380.00	1,999
12/17/2021	Buy	102	$262.50	$26,775.00
11/12/2021	Buy	750	$400.00	$300,000.00
6/27/2018	Buy	200	$505.00	$101,000.00
12/22/2017	Buy	5,102	$98.00	$499,996.00
11/13/2017	Buy	3,340	$129.00	$430,860.00

Dane C. Andreeff Buying and Selling Activity at Helius Medical Technologies

Helius Medical Technologies Company Overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Today's Range

Now: $0.91

$0.70

$1.45

50 Day Range

MA: $0.53

$0.38

$0.91

2 Week Range

Now: $0.91

$0.37

$9.50

Volume

121,971,336 shs

Average Volume

839,833 shs

Market Capitalization

$3.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.68

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad